½ÃÀ庸°í¼­
»óǰÄÚµå
1612827

È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)

Hyaluronic Acid Based Dermal Fillers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå ±Ô¸ð´Â 2024³â 48¾ï ´Þ·¯·Î 2024-2031³â ¿¹Ãø ±â°£ µ¿¾È 7.8%ÀÇ CAGR·Î È®´ëµÇ¾î 2031³â¿¡´Â 81¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯´Â ¼Õ½ÇµÈ È÷¾Ë·ç·Ð»êÀ» º¸ÃæÇÏ¿© ÁÖ¸§À» ÁÙÀ̰í, º¼·ýÀ» ȸº¹Çϰí, ¾ó±¼ÀÇ Æ¯Â¡À» °­È­ÇÏ´Â µ¥ »ç¿ëµÇ´Â ºñ¿µ±¸ÀûÀÎ ÁÖ»ç Ä¡·áÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁøÇÇ ÇÊ·¯´Â ÀÚ¿¬½º·¯¿î °á°ú¿Í ÃÖ¼Òħ½ÀÀû ¼Ö·ç¼ÇÀ» Á¦°øÇϱ⠶§¹®¿¡ ¹Ì¿ë ½Ã¼ú¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÊ·¯ ½ÃÀåÀº ¹Ì¿ë °­È­, ³ëÈ­ ¹æÁö ¼Ö·ç¼Ç ¹× ¾È¸é ȸÃá ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ Àνİú ¼ö¿ëµµ°¡ ³ô¾ÆÁö¸é¼­ ¼¼°è ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¼¼°è È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀåÀº ºñħ½ÀÀû ¹Ì¿ë ½Ã¼ú, ƯÈ÷ ¾ó±¼ ȸÃá¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í °°Àº ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è °í·ÉÈ­ Àα¸ÀÇ Áõ°¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î, ³ëÈ­ÀÇ °¡½ÃÀûÀΠ¡Èĸ¦ ÁÙÀ̱â À§ÇÑ ÇØ°áÃ¥À» ã°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, È÷¾Ë·ç·Ð»ê ÇÊ·¯ ±â¼úÀÇ ¹ßÀüÀº ´õ ¿À·¡ Áö¼ÓµÇ´Â °á°ú¿Í Çâ»óµÈ ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÏ¿© ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½ÀÀû Ä¡·áÀÇ ÀαⰡ ³ô¾ÆÁö¸é¼­ È÷¾Ë·ç·Ð»ê ±â¹Ý ÇÊ·¯ÀÇ ÆíÀǼº°ú È¿°ú¿Í ÇÔ²² ´õ ¸¹Àº »ç¶÷µéÀÌ ÀÌ·¯ÇÑ ½Ã¼úÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ ÇǺΠŸÀÔÀ» À§ÇÑ ´Ù¾çÇÑ Á¦ÇüÀÇ ½ÅÁ¦Ç°ÀÌ Ãâ½ÃµÇ¸é¼­ »õ·Î¿î ½ÃÀå ±âȸ°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ½ÅÈï ½ÃÀåÀÇ ÃÖ¼Òħ½ÀÀû ¹Ì¿ë ¼ºÇü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä«¿Í °°Àº Áö¿ª¿¡¼­ °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´õ ¸¹Àº »ç¶÷µéÀÌ ¼ºÇü¼ö¼úÀ» ¼±ÅÃÇϰí ÀÖÀ¸¸ç, ÀÌ´Â È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯¿¡ ´ëÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. È÷¾Ë·ç·Ð»ê °¡±³ ¹× »ý¹°ÇÐÀû ÀÚ±Ø ±â¼ú°ú °°Àº ÷´Ü ±â¼úÀÇ ÅëÇÕÀº ÇǺΠÇÊ·¯ÀÇ °á°ú¿Í ¾ÈÀü¼ºÀ» Çâ»ó½ÃÄÑ ´õ ¸¹Àº °í°´ÃþÀ» ²ø¾îµéÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ½ºÅ²ÄÉ¾î ºê·£µå¿ÍÀÇ Çù¾÷°ú È÷¾Ë·ç·Ð»ê ÇǺΠÇÊ·¯ÀÇ ÀåÁ¡¿¡ ´ëÇÑ ¼ÒºñÀÚ ±³À° È®´ë´Â ½ÃÀå ÁøÀÔ ±â¾÷µéÀÌ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â ÁÖ¿ä ±âȸÀÔ´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀåÀ» Á¶»çÇÏ¿© Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÀÔ ±â¾÷ °³¿ä µîÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
  • °Å½Ã°æÁ¦ ¿äÀÎ
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

  • Á¦Ç° À¯Çü ä¿ë ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
  • ÁÖ¿ä °Å·¡¿Í ÇÕº´
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
  • È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : Á¦Ç° À¯Çüº°
  • È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : ¿ëµµº°
  • È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : ÃÖÁ¾ ¿ëµµº°

Á¦5Àå È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : Áö¿ªº°

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, Áö¿ªº°, 2019-2023³â
  • ÇöÀç ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°, 2024-2031³â
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦6Àå ºÏ¹ÌÀÇ È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦7Àå À¯·´ÀÇ È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : °ú°Å(2019-2023) ¹× ¿¹Ãø(2024-2031)

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ È÷¾Ë·ç·Ð»ê ±â¹Ý ÇǺΠÇÊ·¯ ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ½ÃÀå ±¸Á¶
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±ÙÀÇ µ¿Çâ)
    • Allergan Aesthetics(AbbVie Inc.)
    • Galderma
    • Anika Therapeutics Inc.
    • Merz Pharmaceuticals
    • Genzyme Corporation
    • Bio plus Co. Ltd.
    • LG Life Sciences
    • Sinclair Pharma
    • Sculpt Luxury
    • Dermal Fillers Ltd.
    • Bioxis Pharmaceutical
    • Sinclair Pharma; Laboratories
    • Bohus BioTech AB

Á¦13Àå ºÎ·Ï

ksm 24.12.24

Persistence Market Research has recently released a comprehensive report on the global market for Hyaluronic Acid Based Dermal Fillers. This report provides an in-depth analysis of the key market dynamics, including growth drivers, trends, opportunities, and challenges, offering valuable insights into the market structure. The publication also presents exclusive data and forecasts that outline the expected growth trajectory of the global Hyaluronic Acid Based Dermal Fillers Market from 2024 to 2031.

Key Insights:

  • Hyaluronic Acid Based Dermal Fillers Market Size (2024E): US$ 4.8 Bn
  • Projected Market Value (2031F): US$ 8.1 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.8%

Hyaluronic Acid Based Dermal Fillers Market - Report Scope:

Hyaluronic acid-based dermal fillers are non-permanent injectable treatments used to reduce wrinkles, restore volume, and enhance facial features by replenishing lost hyaluronic acid. These dermal fillers are widely popular in aesthetic procedures, as they provide a minimally invasive solution with natural-looking results. The market for these fillers is rapidly expanding due to the rising demand for cosmetic enhancements, anti-aging solutions, and facial rejuvenation procedures. Additionally, growing awareness and acceptance of aesthetic treatments are fueling market growth globally.

Market Growth Drivers:

The global Hyaluronic Acid Based Dermal Fillers market is propelled by several factors, including the increasing desire for non-invasive cosmetic procedures, particularly for facial rejuvenation. The growing aging population worldwide is a key driver, as individuals seek solutions to reduce the visible signs of aging. Furthermore, the advancements in hyaluronic acid filler technology, which offer longer-lasting results and increased safety profiles, are contributing to market expansion. The rising popularity of minimally invasive treatments, combined with the convenience and effectiveness of hyaluronic acid-based fillers, is attracting more individuals to undergo these procedures. Additionally, the availability of new product variants with different formulations for various skin types is opening up new market opportunities.

Market Restraints:

Despite strong growth prospects, the market faces challenges related to the high cost of treatments and the potential side effects of dermal fillers, such as bruising, swelling, and allergic reactions. The need for skilled professionals to administer these treatments also limits accessibility in certain regions, especially in developing economies. Moreover, the lack of standardization in the hyaluronic acid filler market, along with concerns over counterfeit products, poses a challenge for industry growth. Regulatory hurdles and the potential for complications related to the use of dermal fillers may also hinder the market's expansion.

Market Opportunities:

The market presents significant growth opportunities driven by the increasing demand for minimally invasive cosmetic procedures in emerging markets. As disposable income rises in regions like Asia Pacific and Latin America, more individuals are opting for cosmetic enhancements, creating a demand for hyaluronic acid-based dermal fillers. The integration of advanced technologies such as hyaluronic acid crosslinking and bio-stimulation techniques is expected to enhance the results and safety of dermal fillers, thereby attracting a larger customer base. Furthermore, collaborations with skincare brands and expanding consumer education on the benefits of hyaluronic acid dermal fillers are key opportunities for market players to grow their presence.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Hyaluronic Acid Based Dermal Fillers market?
  • How are advancements in hyaluronic acid technology influencing the market dynamics?
  • Who are the major players in the market, and what strategies are they employing to maintain their competitive advantage?
  • What are the emerging trends in the global Hyaluronic Acid Based Dermal Fillers market, and what is the future outlook?
  • How are market players addressing challenges related to safety, regulation, and product quality?

Competitive Intelligence and Business Strategy:

Leading companies in the global Hyaluronic Acid Based Dermal Fillers market, including Allergan (AbbVie Inc.), Revance Therapeutics, Inc., Galderma S.A., Ipsen Pharma, and Medytox Inc., focus on product innovation and expanding their portfolios of hyaluronic acid-based fillers. These companies invest heavily in research and development to improve the safety, effectiveness, and longevity of their products. Additionally, strategic partnerships and collaborations with aesthetic clinics and professionals are helping them expand their market share. Brand awareness campaigns, customer education programs, and the launch of new product variants targeting different age groups and skin types are also key strategies employed by leading players.

Key Companies Profiled:

  • Allergan Aesthetics (AbbVie Inc.)
  • Galderma
  • Anika Therapeutics Inc.
  • Merz Pharmaceuticals
  • Genzyme Corporation
  • Bio plus Co. Ltd.
  • LG Life Sciences
  • Sinclair Pharma
  • Sculpt Luxury
  • Dermal Fillers Ltd.
  • Bioxis Pharmaceutical
  • Sinclair Pharma; Laboratories
  • Bohus BioTech AB

Market Segmentation

By Product Type

  • Single Phase Products
  • Duplex Products

By Application

  • Wrinkle Removal
  • Lip Augmentation
  • Rhinoplasty
  • Others

By End User

  • Specialty and Dermatology Clinics
  • Hospitals and Clinics
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Hyaluronic Acid Based Dermal Fillers Market Snapshot, 2024 - 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
    • 3.3.1. List of Distribution Channel/Marketplaces
      • 3.3.1.1. Retail
      • 3.3.1.2. Audiology
      • 3.3.1.3. E-Commerce
    • 3.3.2. List of End User (Industry)
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 4.3. Hyaluronic Acid Based Dermal Fillers Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
      • 4.3.3.1. Single Phase Products
      • 4.3.3.2. Duplex Products
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Hyaluronic Acid Based Dermal Fillers Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
      • 4.4.3.1. Wrinkle Removal
      • 4.4.3.2. Lip Augmentation
      • 4.4.3.3. Rhinoplasty
      • 4.4.3.4. Others
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Hyaluronic Acid Based Dermal Fillers Market Outlook: End-use
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019 - 2023
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
      • 4.5.3.1. Specialty & Dermatology Clinics
      • 4.5.3.2. Hospitals & Clinics
      • 4.5.3.3. Others
    • 4.5.4. Market Attractiveness Analysis: End-use

5. Hyaluronic Acid Based Dermal Fillers Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Application
    • 6.2.4. By End-use
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 6.4.1. Single Phase Products
    • 6.4.2. Duplex Products
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 6.5.1. Wrinkle Removal
    • 6.5.2. Lip Augmentation
    • 6.5.3. Rhinoplasty
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 6.6.1. Specialty & Dermatology Clinics
    • 6.6.2. Hospitals & Clinics
    • 6.6.3. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Application
    • 7.2.4. By End-use
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 7.4.1. Single Phase Products
    • 7.4.2. Duplex Products
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 7.5.1. Wrinkle Removal
    • 7.5.2. Lip Augmentation
    • 7.5.3. Rhinoplasty
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 7.6.1. Specialty & Dermatology Clinics
    • 7.6.2. Hospitals & Clinics
    • 7.6.3. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Application
    • 8.2.4. By End-use
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 8.4.1. Single Phase Products
    • 8.4.2. Duplex Products
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 8.5.1. Wrinkle Removal
    • 8.5.2. Lip Augmentation
    • 8.5.3. Rhinoplasty
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 8.6.1. Specialty & Dermatology Clinics
    • 8.6.2. Hospitals & Clinics
    • 8.6.3. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Application
    • 9.2.4. By End-use
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 9.4.1. Single Phase Products
    • 9.4.2. Duplex Products
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 9.5.1. Wrinkle Removal
    • 9.5.2. Lip Augmentation
    • 9.5.3. Rhinoplasty
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 9.6.1. Specialty & Dermatology Clinics
    • 9.6.2. Hospitals & Clinics
    • 9.6.3. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Application
    • 10.2.4. BY End-use
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 10.4.1. Single Phase Products
    • 10.4.2. Duplex Products
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 10.5.1. Wrinkle Removal
    • 10.5.2. Lip Augmentation
    • 10.5.3. Rhinoplasty
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 10.6.1. Specialty & Dermatology Clinics
    • 10.6.2. Hospitals & Clinics
    • 10.6.3. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Application
    • 11.2.4. By End-use
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 11.4.1. Single Phase Products
    • 11.4.2. Duplex Products
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 11.5.1. Wrinkle Removal
    • 11.5.2. Lip Augmentation
    • 11.5.3. Rhinoplasty
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 11.6.1. Specialty & Dermatology Clinics
    • 11.6.2. Hospitals & Clinics
    • 11.6.3. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Allergan Aesthetics (AbbVie Inc.)
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Galderma
    • 12.3.3. Anika Therapeutics Inc.
    • 12.3.4. Merz Pharmaceuticals
    • 12.3.5. Genzyme Corporation
    • 12.3.6. Bio plus Co. Ltd.
    • 12.3.7. LG Life Sciences
    • 12.3.8. Sinclair Pharma
    • 12.3.9. Sculpt Luxury
    • 12.3.10. Dermal Fillers Ltd.
    • 12.3.11. Bioxis Pharmaceutical
    • 12.3.12. Sinclair Pharma; Laboratories
    • 12.3.13. Bohus BioTech AB

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦